Klox Technologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Klox Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11168
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Klox Technologies Inc (Klox Technologies) is a biomedical technology company that researches, develops and commercializes fluorescence biomodulation (FB) technology products for the treatment of skin and soft tissue disorders. The company develops FB systems to address conditions in the therapeutic areas of dermatology, wound care, animal health, and oral health. Its product pipeline includes Kleresca, for treatment of acne vulgaris and skin care; LumiHeal, for treating chronic wounds, perio-1, for treating periodontitis; and phovia, for the treatment of wounds in animals. It caters to biotechnology, pharmaceutical and medical device industries. The company has operations in Canada, Denmark, Ireland, the US and Italy. Klox Technologies is headquartered in Laval, Quebec, Canada.

Klox Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Klox Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Licensing Agreements 14
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Equity Offering 15
Klox Technologies Withdraws IPO 15
Klox Technologies Inc – Key Competitors 16
Klox Technologies Inc – Key Employees 17
Klox Technologies Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Klox Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klox Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Klox Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Klox Technologies Withdraws IPO 15
Klox Technologies Inc, Key Competitors 16
Klox Technologies Inc, Key Employees 17
Klox Technologies Inc, Other Locations 18
Klox Technologies Inc, Subsidiaries 18

List of Figures
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Klox Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Klox Technologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MMRGlobal Inc (MMRF)-医療機器分野:企業M&A・提携分析
    Summary MMRGlobal Inc (MMRGlobal), formerly MMR Information Systems, Inc., is a personal health records company, which provides Personal Health Record (PHR) products and electronic safe deposit box storage solutions. It offers a wide range of secure, online products that helps consumers and professi …
  • Cameco Corporation:企業のM&A・事業提携・投資動向
    Cameco Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cameco Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • PT Gudang Garam Tbk:企業の戦略・SWOT・財務情報
    PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nova Kreditna banka Maribor d. d.:企業の戦略・SWOT・財務分析
    Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report Summary Nova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kyochon F&B Co., Ltd.:企業の戦略・SWOT・財務分析
    Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Flex Foods Ltd:企業の戦略・SWOT・財務情報
    Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Motor Oil (Hellas) Corinth Refineries SA (MOH):石油・ガス:M&Aディール及び事業提携情報
    Summary Motor Oil (Hellas) Corinth Refineries SA (MOH) is an independent oil refining company. It produces and markets petroleum products, which include gasoline, diesel, fuel oil, asphalt, jet fuel, lubricants and others. MOH operates refinery complex in Corinth, which includes crude distillation u …
  • Qube Holdings Ltd:企業の戦略・SWOT・財務情報
    Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Titan Pharmaceuticals Inc (TTNP):企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • E.ON UK Plc:企業の戦略的SWOT分析
    E.ON UK Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sociedad General de Aguas de Barcelona SA:企業の戦略的SWOT分析
    Sociedad General de Aguas de Barcelona SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Sunstar Holding AG:戦略・SWOT・企業財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • P.F. Chang’s China Bistro, Inc.:企業の戦略・SWOT・財務情報
    P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report Summary P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Electrabel SA-エネルギー分野:企業M&A・提携分析
    Summary Electrabel S.A. (Electrabel) is an energy utility company. It produces and sells electricity; supplies natural gas; and provides related energy products and services. The company operates diversified electricity generating facilities such as thermal, nuclear and renewable power plants, inclu …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner) a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer components …
  • Endo Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Endo Pharmaceuticals Inc (Endo Pharmaceuticals), a subsidiary of Endo International plc is a healthcare products provider that offers medicinal products. The company manufactures and distributes generic pharmaceutical products and over-the-counter medications. Its products include testostero …
  • Genentech, Inc.:企業の戦略・SWOT・財務情報
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cidara Therapeutics Inc (CDTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆